89bio stock falls following public offering announcement
Shares of 89bio, Inc. (NASDAQ:ETNB) tumbled 6% after the company announced its plans for an underwritten public offering of common stock and pre-funded warrants. The clinical-stage biopharmaceutical company,
BriaCell Therapeutics Announces Pricing of Public Offering
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Butterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ult
BriaCell announces public offering of common shares
PHILADELPHIA and VANCOUVER, British Columbia - BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in immunotherapies for cancer care, announced today its plans to conduct a best-efforts public offering of common shares.
GH Research Announces Proposed Public Offering
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the commencement of an underwritten public offering in the United States of $150 million of ordinary shares.
Decent Holding Inc. Announces Pricing of Initial Public Offering
Decent Holding Inc. (the “Company”), an established wastewater treatment services provider in China, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
(GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD),
Annovis Bio announces pricing of $21M offering of stock, warrants
Annovis Bio (ANVS) announced the pricing of an underwritten public offering of 5.25M shares of common stock and warrants to purchase 5,250,000
Business Wire3d
Atlas Energy Solutions Announces Pricing of Upsized Underwritten Public Offering of Common Stock
Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer ...
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is ...
Morningstar7d
Akero Therapeutics Announces Proposed Public Offering of Common Stock
In addition, Akero intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less underwriting ...
When Did Facebook (Meta) Go Public?
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
AgWeb13d
Smithfield Foods Announces Launch of Initial Public Offering
Smithfield Foods, Inc., announced that it has “commenced the roadshow” for an underwritten initial public offering of ...
Morningstar8d
The Marygold Companies, Inc. Announces Pricing of $2.25 Million Public Offering
The Marygold Companies, Inc. (“TMC” or the “Company”), (NYSE American: MGLD), a diversified global holding company, today announced the pricing of an underwritten public offering of 2,050 ...